Northland Cuts Boston Scientific (BSX) to Market Perform Amid Sales Concerns
Tweet
Share
E-mailGet Alerts BSX Hot Sheet
Price: $49.37 --0%
Rating Summary:
33 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Rating Summary:
33 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Join SI Premium – FREE
Northland Securities downgraded Boston Scientific (NYSE: BSX) from Outperform to Market Perform.
The call follows Q2 results and Q3 and FY12 guidance from Boston Scientific on Thursday morning.
Northland was not impressed with Boston Scientific's top-line result, citing weakness related to the company's top two heart-device markets. "Revenue is clearly not as stable as anticipated, and did not accelerate this quarter despite new products," according to the firm.
For an analyst ratings summary and ratings history on Boston Scientific click here. For more ratings news on Boston Scientific click here.
The call follows Q2 results and Q3 and FY12 guidance from Boston Scientific on Thursday morning.
Northland was not impressed with Boston Scientific's top-line result, citing weakness related to the company's top two heart-device markets. "Revenue is clearly not as stable as anticipated, and did not accelerate this quarter despite new products," according to the firm.
For an analyst ratings summary and ratings history on Boston Scientific click here. For more ratings news on Boston Scientific click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lowe's (LOW) PT Lowered to $275 at Guggenheim
- CrowdStrike (CRWD) PT Lowered to $227 at Scotiabank
- Kepler Cheuvreux Starts Jet2 plc (JET2:LN) (DRTGF) at Buy
Create E-mail Alert Related Categories
DowngradesRelated Entities
Northland Securities, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
